Go

Intern, International Pricing & Market Access

bei Blueprint Medicines in Zug, CH

Arbeitsform: Vor Ort | Beschäftigungsart: Vollzeit

Erfahrungsstufe: Einsteiger | Veröffentlicht: 24.04.2025

Jetzt bewerben

Beschreibung

Location(s): Zug, Switzerland

Position type: Intern

Reporting Line: Director, International Pricing & Market Access

 

How will your role help us transform hope into reality?

This 6-month internship (full-time or 4 days per week) will serve as an introduction to International Pricing and Market Access.  This is a fantastic opportunity for students who have just finished their university cycle or who are still enrolled in a university degree program to gain exposure to the crucial functions in an International start-up biotech environment.  Within Market Access, you will gain exposure to the complex international pricing system, market access and the health technology assessment processes.   The internship will start on September 1st.

 

What will you do?

Projects will be crafted along one or multiple of the following key areas based on interest and business needs:

• Market Access:
  • Shadow the International Pricing & Market Access team to gain understanding of the complex market access and pricing process
  • Assist in pricing data collection, analysis and market access strategy development for existing and new products
  • Monitor international reference pricing (IRP) trends and their impact on local pricing strategies
  • Assist the director in the market access internal educational materials and communications
  • Conduct desk research on healthcare policies, reimbursement landscapes, and pricing regulations across different markets
  • Contribute to the preparation of value dossiers, payer presentations, and pricing submissions
  • Assist in the development of health economic models, budget impact analyses, and cost-effectiveness assessments.
  • Provide support for internal and external stakeholder engagement, including regulatory authorities, payers, and market access consultants
•  On-site Expectations:
  • While blueprint offers flexibility to work from home, you will gain the most of this experience by being on-site and learning first-hand from the key functional stakeholders.  For this reason, we request presence in the office at least twice per week, to be agreed with functional managers. 

What minimum qualifications do we require?

• You are currently enrolled in a Bachelors or Masters degree or you have just completed your Bachelors or Masters degree

 

What additional qualifications will make you a stronger candidate?

• MAJOR OR AREA OF STUDY: Economics, Public Health, Health Economics, Health Management, and/or Life science related disciplines (e.g. Pharmacy, Life Sciences, or a related field.)
• BROAD AREAS OF INTEREST: pricing, market Access, health technology assessment, healthcare systems, drug development, lifecycle management

• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

 

 

Why Blueprint? 

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

 

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

*Blueflex is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in-person work with the benefits of added flexibility.  Blueflex allows for mix of in-office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources.  It is a culture enhancer.